Skip to main navigation Skip to search Skip to main content

A Randomized, Blinded, Placebo- and Active Comparator-controlled Phase 2B Trial of the Combination of SJ733 and Tafenoquine for Radical Cure of P. Vivax Malaria in Comparison to Chloroquine-Tafenoquine

Press/Media: Press / Media

PeriodMar 5 2026

Media coverage

1

Media coverage

  • TitleA Randomized, Blinded, Placebo- and Active Comparator-controlled Phase 2B Trial of the Combination of SJ733 and Tafenoquine for Radical Cure of P. Vivax Malaria in Comparison to Chloroquine-Tafenoquine
    Media name/outletDisease Prevention Daily
    Country/TerritoryUnited States
    Date3/5/26
    PersonsMichael Smith